Présentation de l'entreprise
Braskem S.A. operates within the Basic Materials sector, specifically focusing on the Chemicals industry, where it engages in the manufacture, sale, import, and export of essential chemicals, petrochemicals, and fuels in Brazil. The company's core production capabilities include polyethylene (PE), polypropylene, tertiary-butyl ethyl ether, gasoline, benzene, toluene, xylene, ethylene, propylene, and polyvinyl derivatives. As of the latest available data, the entity holds a market capitalization of $1.45B and reports an annual revenue of $70.72B, while the specific count of employees is not disclosed in the provided facts. These financial metrics position Braskem as a significant player in the petrochemical landscape, with a revenue figure that suggests substantial operational scale despite the relatively modest market capitalization, indicating a potential divergence between current share valuation and underlying asset base or future growth expectations.
Santé financière
The company reported a total revenue of $70.72B over the trailing twelve months, yet this was accompanied by a net income of $-9,880,000,512, revealing a substantial gap that highlights significant cost structures or non-operating expenses eroding profitability. Despite the negative net income, the entity generated an EBITDA of $4.02B, suggesting that operational cash generation remains positive before financing costs and tax impacts. However, the free cash flow stands at $-5,425,999,872, indicating that capital expenditures or working capital requirements have exceeded the cash generated from operations, which limits immediate financial flexibility for discretionary spending or aggressive debt repayment without external financing. Margin analysis shows a Gross Margin of 4.8%, an Operating Margin of 15.0%, and a Profit Margin of -14.0%; the wide disparity between the positive operating margin and negative profit margin underscores the heavy impact of interest, taxes, or other non-operating items on the final bottom line. The balance sheet presents a challenging picture with total debt of $71.32B against cash reserves of $11.84B, resulting in a negative debt-to-equity ratio metric and significant net leverage. Short-term liquidity is constrained, as evidenced by a Current Ratio of 0.76, which indicates that current assets are insufficient to cover current liabilities without relying on asset sales or new financing. Furthermore, the Return on Equity is listed as N/A due to the equity structure or negative equity balance, while the Return on Assets stands at 0.2%, reflecting minimal efficiency in generating profits relative to the total asset base employed.
Évaluation de la valorisation
The valuation metrics present a complex picture with a Trailing Twelve Months P/E Ratio of N/A and a Forward P/E of -4.58, implying that the market is pricing in expectations of future earnings recovery rather than current profitability. The Price to Book ratio is -0.94, which typically suggests the market is valuing the company at less than its book value, often seen in distressed situations or industries with significant intangible assets or cyclical downturns. Alternative valuation measures such as the Price to Sales ratio of 0.02 and an EV/EBITDA of 15.45 provide context; the extremely low P/S ratio indicates the stock trades at a fraction of its sales, while the positive EV/EBITDA suggests that earnings before interest, taxes, depreciation, and amortization remain robust enough to support the enterprise value despite the negative net income. The stock's recent price action is bounded by a 52-Week High of $5.29 and a 52-Week Low of $2.32, meaning the current share price is trading within this established volatility range. Additionally, the Beta of 0.75 indicates that Braskem S.A. exhibits lower volatility than the broader market, moving approximately 25% less than the market index on average during periods of price fluctuation.
Growth & Income
Revenue growth year-over-year has contracted by -15.9%, while earnings growth is not applicable given the negative net income, suggesting that the decline in sales has directly impacted profitability without a decoupling of the two metrics. The company does not distribute dividends, as indicated by a Dividend Yield of N/A and a Payout Ratio of 0.0%, which means that all available earnings, including the current losses, are theoretically retained to fund operations or reduce debt rather than being returned to shareholders. This reinvestment strategy is necessitated by the current financial constraints, as paying dividends would be unsustainable given the negative net income and negative free cash flow. Consequently, the overall growth and income profile for Braskem S.A. is characterized by a contraction in revenue and a complete absence of dividend income, relying instead on operational turnaround to restore profitability and potentially unlock value for equity holders in the future.